BRÈVE publiée le 26/09/2025 à 14:50, il y a 6 mois 22 jours EnVVeno Medical Engages in Virtual Investor Segment Amid FDA Appeal Medical Devices EnVVeno Medical VenoValve Chronic Venous Insufficiency FDA Appeal
COMMUNIQUÉ DE PRESSE publié le 26/09/2025 à 14:45, il y a 6 mois 22 jours enVVeno Medical (NASDAQ:NVNO) Participates in Virtual Investor "What This Means" Segment enVVeno Medical Corporation announces CEO Robert Berman's participation in a Virtual Investor segment discussing the supervisory appeal for VenoValve® with FDA FDA EnVVeno Medical VenoValve Virtual Investor Supervisory Appeal
BRÈVE publiée le 15/09/2025 à 14:50, il y a 7 mois 3 jours EnVVeno Medical dépose un recours auprès de la FDA EnVVeno Medical Insuffisance Veineuse Chronique Valve VenoValve Appel Auprès De La FDA Processus Réglementaire
BRÈVE publiée le 15/09/2025 à 14:50, il y a 7 mois 3 jours EnVVeno Medical Pursues FDA Supervisory Appeal EnVVeno Medical VenoValve Chronic Venous Insufficiency Regulatory Process FDA Appeal
COMMUNIQUÉ DE PRESSE publié le 15/09/2025 à 14:45, il y a 7 mois 3 jours enVVeno Medical Updates Regulatory Status of VenoValve(R) enVVeno Medical Corporation to file supervisory appeal with FDA regarding not-approvable letter for VenoValve® submission to treat deep venous CVI, aiming to bring innovative solution to patients FDA EnVVeno Medical Corporation VenoValve® Deep Venous Disease Supervisory Appeal
BRÈVE publiée le 20/08/2025 à 13:05, il y a 7 mois 29 jours EnVVeno Medical Receives Not-Approvable Letter from FDA for VenoValve EnVVeno Medical VenoValve FDA Decision Deep Venous Disease Premarket Approval
BRÈVE publiée le 20/08/2025 à 13:05, il y a 7 mois 29 jours EnVVeno Medical reçoit une lettre de non-approbation de la FDA pour VenoValve EnVVeno Medical Valve VenoValve Décision De La FDA Maladie Veineuse Profonde Approbation Préalable À La Mise Sur Le Marché
COMMUNIQUÉ DE PRESSE publié le 20/08/2025 à 13:00, il y a 7 mois 29 jours enVVeno Receives Not-Approvable Letter from the FDA for the VenoValve(R) enVVeno Medical received a not-approvable letter from the FDA for VenoValve, citing lacking hemodynamic data and safety concerns. Company to work on new criteria and potential resubmission FDA Medical Device EnVVeno Medical VenoValve CVI
BRÈVE publiée le 15/08/2025 à 15:26, il y a 8 mois 3 jours EnVVeno Medical participera à la série de webinaires financiers Webull EnVVeno Medical Valve VenoValve Maladie Veineuse Profonde Webull Financial Biotechnologie/Technologie Médicale
BRÈVE publiée le 15/08/2025 à 15:26, il y a 8 mois 3 jours EnVVeno Medical to Present at Webull Financial Webinar Series EnVVeno Medical VenoValve Deep Venous Disease Webull Financial Biotech/MedTech
Publié le 17/04/2026 à 20:30, il y a 1 jour 10 heures ALTAREA - Déclaration d’opérations sur actions propres
Publié le 17/04/2026 à 19:00, il y a 1 jour 11 heures Cegedim : Publication du Document d’Enregistrement Universel 2025
Publié le 17/04/2026 à 19:00, il y a 1 jour 11 heures Cegedim: Release of its 2025 Universal Registration Document
Publié le 17/04/2026 à 17:45, il y a 1 jour 12 heures Carrefour announces the sale of its minority stake in CarrefourSA in Turkey to Aydın
Publié le 17/04/2026 à 17:45, il y a 1 jour 12 heures Carrefour annonce la cession de sa participation minoritaire dans CarrefourSA en Turquie à Aydın
Publié le 18/04/2026 à 04:00, il y a 1 jour 2 heures Formation Metals Responds to OTC Markets Request on Recent Promotional Activity
Publié le 18/04/2026 à 02:00, il y a 1 jour 4 heures AI/ML Innovations Announces Completion of Share Issuance
Publié le 18/04/2026 à 01:35, il y a 1 jour 4 heures Medicure Announces Resignation of President and Chief Operating Officer
Publié le 18/04/2026 à 01:00, il y a 1 jour 5 heures Onco-Innovations Strengthens Executive Leadership with Appointment of Dr. Islam Mohamed as Chief Medical Officer and Stephen M. Novak as Chief of Research and Development
Publié le 18/04/2026 à 00:00, il y a 1 jour 6 heures Redwood AI Announces Collaboration with Aidos Innovations, Aimed at Enhancing Public Safety Collaboration with B.C. Government, Canadian Federal and Local Law Enforcement Agencies to Tackle the Fentanyl Crisis in British Columbia
Publié le 18/04/2026 à 00:05, il y a 1 jour 6 heures ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
Publié le 17/04/2026 à 21:39, il y a 1 jour 8 heures Linedata Services: Mise à disposition du Document d’Enregistrement Universel 2025 incluant le Rapport Financier Annuel 2025
Publié le 17/04/2026 à 20:33, il y a 1 jour 9 heures LLB General Meeting 2026 – Shareholders approve all proposals of the Board of Directors
Publié le 17/04/2026 à 19:30, il y a 1 jour 11 heures KAP AG: REFINANCING CONCEPT AGREED; NEW SYNDICATED LOAN SECURES FLEXIBILITY FOR THE ONGOING TRANSFORMATION PROCESS
